Top Pharma Companies in India by Market Cap

BSE Sensex 74638.52 220.47 (-0.29%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
61	Ipca Laboratories Ltd.	Q V+ PT	51,020 Mid Cap	2,005 (-0.15%)	40.96	6.1	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Strides Pharma Science Ltd.	Q V+ PT	11,245 Small Cap	1,227.55 (-0.76%)	18.58	3.48	7.94	21.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	Cipla Ltd.	Q V PT	1,10,794 Large Cap	1,370.90 (-1.02%)	33.19	3.18	8.01	10.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Indoco Remedies Ltd.	Q V+ PT	2,302 Small Cap	257.35 (0.21%)	421.02	2.37	8.25	-199.84	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	Amrutanjan Health Care Ltd.	Q V+ PT	1,427 Small Cap	501 (1.12%)	26.54	3.82	8.59	1.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Divis Laboratories Ltd.	Q V+ PT	2,48,664 Large Cap	9,404.50 (-0.29%)	85.6	14.18	8.67	4.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Morepen Laboratories Ltd.	Q V+ PT	6,625 Small Cap	119.65 (-2.21%)	47.71	5.15	8.73	-11.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Emcure Pharmaceuticals Ltd.	Q V+ PT	38,241 Small Cap	2,005.50 (0.23%)	37.53	7.26	8.73	13.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Hester Biosciences Ltd.	Q V PT	1,861 Small Cap	2,190.75 (0.20%)	13.66	4.09	9.19	6.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	Glenmark Pharmaceuticals Ltd.	Q V+ PT	67,169 Mid Cap	2,464.20 (0.58%)	38.46	6.31	9.19	22.19	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Syngene International Ltd.	Q V+ PT	14,905 Small Cap	377.30 (-2.09%)	67.99	3.34	9.45	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	SMS Pharmaceuticals Ltd.	Q V+ PT	4,148 Small Cap	485.45 (4.07%)	42.66	5.42	9.51	7.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Advanced Enzyme Technologies Ltd.	Q V PT	3,227 Small Cap	297 (1.04%)	41.06	4.55	9.82	13.51	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Akums Drugs & Pharmaceuticals Ltd.	Q V+ PT	12,339 Small Cap	817.35 (-0.47%)	44.31	3.78	9.87	8.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	FDC Ltd.	Q V PT	5,746 Small Cap	358.60 (-1.09%)	19.96	2.25	9.91	0.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Bliss GVS Pharma Ltd.	Q V+ PT	7,235 Small Cap	687.75 (4.59%)	51.34	5.67	9.94	8.65	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	Abbott India Ltd.	Q V PT	57,954 Mid Cap	27,155 (0.71%)	35.48	11.07	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Lincoln Pharmaceuticals Ltd.	Q V PT	1,215 Small Cap	602.55 (-0.53%)	12.58	1.53	10.03	10.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	Wanbury Ltd.	Q V+ PT	780 Small Cap	225 (-1.27%)	18.54	11.88	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Metropolis Healthcare Ltd.	Q V PT	12,396 Small Cap	595.75 (0.18%)	61.19	7.91	10.52	0.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	Alkem Laboratories Ltd.	Q V PT	65,780 Mid Cap	5,385 (0.65%)	29.65	4.47	10.66	8.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Thyrocare Technologies Ltd.	Q V+ PT	8,848 Small Cap	589.15 (3.08%)	51.6	14.45	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	Shilpa Medicare Ltd.	Q V+ PT	19,967 Small Cap	1,051.45 (-1.81%)	70.44	7.8	11.30	12.66	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	Concord Biotech Ltd.	Q V PT	15,629 Small Cap	1,544.65 (-2.28%)	60.05	7.98	11.33	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,40,398 Large Cap	1,847 (-1.12%)	37.05	5.18	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,82,738 Large Cap	4,959.45 (-0.17%)	86.64	21.05	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Dr. Reddys Laboratories Ltd.	Q V PT	97,749 Mid Cap	1,213.80 (0.98%)	31.14	2.63	12.09	15.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Dr. Lal Pathlabs Ltd.	Q V PT	31,822 Small Cap	1,918.80 (0.13%)	59.04	12.5	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	Unichem Laboratories Ltd.	Q V PT	3,841 Small Cap	550.70 (2.06%)	12.46	1.38	12.26	24.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Lupin Ltd.	Q V PT	98,070 Mid Cap	2,122.95 (0.14%)	17.53	4.07	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	28.97	9.73%
Ind-Swift Labs.	409.95	7.44%
Aarti Pharmalabs	893	5.50%
Shukra Pharmaceut.	58.14	5.25%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Guj. Kidney & Super	175.95	-3.93%
Kopran	272.15	-3.85%
Kwality Pharma	3,700	-3.57%
Acutaas Chemicals	3,312.70	-3.20%
Concord Biotech	1,544.65	-2.28%

News about Top Pharma Companies in India

Sep, 2026

Glenmark Pharmaceuticals informs about analyst meet

Pursuant to the Regulation 30 and Para A of Part A of Schedule III of the SEBI LODR, Glenmark Pharmaceuticals has informed that the company will be meeting Investor/Analyst (Participants) in PL Capital - Emerging Titans 2026 Conference on 29-09-2026. No unpublished price sensitive information is proposed to be shared during the meeting.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Concord Biotech informs about board meeting

Pursuant to Regulation 29(1) of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, Concord Biotech has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, September 23, 2026 to consider the proposal for declaration of bonus equity shares to the existing equity shareholders of the Company in accordance with the applicable provisions, subject to approval of the shareholders of the Company. Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and Clause 9 of the Code for Prevention of Insider Trading in the securities of the Company, the company has informed that the Trading Window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives from today i.e. September 19, 2026 till 48 hours after the declaration of outcome of Board Meeting. The trading window shall be opened with effect from September 26, 2026.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Unichem Laboratories informs about disclosure

Unichem Laboratories has informed that with reference to earlier intimation dated 24th January 2025, the Company has received Order-In-Appeal from Commissioner (Appeals Thane). Relevant details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are provided in Annexure A. The Company shall take all appropriate remedial steps including filing of an appeal within prescribed timelines.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Indoco Remedies gets nod to incorporate wholly owned subsidiary

The committee of executive directors of the company in its meeting held on September 18, 2026 has considered and approved the same

Sep, 2026

USFDA concludes surveillance inspection at Shilpa Medicare’s Hyderabad unit

At the conclusion of the inspection, the USFDA issued one observation, which is procedural in nature

Sep, 2026

USFDA completes inspection at Concord Biotech’s formulation facility in Gujarat

The inspection was successfully completed on September 18, 2026 and at the conclusion, the USFDA has issued one minor observation

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Take Ltd.	238 Crore
2	Suven Life Sciences Ltd.	9,679 Crore
3	Aster DM Quality Care Ltd.	65,885 Crore
4	Aurobindo Pharma Ltd.	99,828 Crore
5	Ind-Swift Laboratories Ltd.	3,245 Crore
6	Solara Active Pharma Sciences Ltd.	3,574 Crore
7	Hikal Ltd.	2,788 Crore
8	Fabtech Technologies Ltd.	659 Crore
9	Sanofi Consumer Healthcare India Ltd.	9,249 Crore
10	Tarsons Products Ltd.	1,631 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,959	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,019	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,696	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,405	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,464	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,518	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,172	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,922	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,604	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,123	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,464	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,155	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,214	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Glenmark Pharmaceuticals informs about analyst meet

Concord Biotech informs about board meeting

Unichem Laboratories informs about disclosure

Indoco Remedies gets nod to incorporate wholly owned subsidiary

USFDA concludes surveillance inspection at Shilpa Medicare’s Hyderabad unit

USFDA completes inspection at Concord Biotech’s formulation facility in Gujarat

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?